Back to Trades
Gano Kyle
Chief Executive OfficerDirectorCIK 0001567160
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2026
Gano Kyle, Chief Executive Officer, Director, has filed 4 SEC reports (2026), all concentrated in NEUROCRINE BIOSCIENCES INC (NBIX), totaling $23.9M in disclosed volume. Weighing $0 bought versus $4.8M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Sep 15 | NBIX NEUROCRINE BIOSCIENCES INC | Gano Kyle | Chief Executive Officer, Director | Grant | $684.2K |
| Feb 17 | NBIX NEUROCRINE BIOSCIENCES INC | Gano Kyle | Chief Executive Officer, Director | Grant | $15.6M |
| Feb 3 | NBIX NEUROCRINE BIOSCIENCES INC | Gano Kyle | Chief Executive Officer, Director | Exercise | $215.0K |
| Jan 20 | NBIX NEUROCRINE BIOSCIENCES INC | Gano Kyle | Chief Executive Officer, Director | Sell | $4.8M |
4 filings